Pediatric Alopecia Areata Correlates With Autoimmune and Metabolic Disorders
The prevalence of comorbidities in pediatric patients with alopecia areata was determined, using a large de-identified aggregated patient database.
Systemic Lupus Erythematosus
Newly Diagnosed Lupus Erythematosus Could Potentially Be Drug Induced
A new case of cutaneous lupus erythematosus or systemic lupus erythematosus could potentially be drug induced.
Combined Fractional Microneedle Radiofrequency With Ablative Fractional Laser for Acne Treatment
Findings from the first effort to assess the effects of FMRF/AFL combination treatment as well as the use of FMRF with concomitant isotretinoin therapy.
National Rosacea Society Publishes Updated Guideline on Standard Rosacea Management
An update to rosacea treatment guidelines provides a comprehensive summary of management options, including expert evaluations–based on the phenotypes of each patient–to serve as a guide for tailoring treatment and care.
CDC: Racial Disparity Seen With Lupus-Related Deaths
Mortality from systemic lupus erythematosus (SLE) is significantly higher among blacks.
Adverse Childhood Experiences Associated With Worse Lupus Outcomes
Adverse childhood experiences (ACEs) are associated with worse patient-reported systemic lupus erythematosus (SLE) outcomes.
Lupus Affects Emotional, Mental Well-Being of Patients
More than 60 percent of patients with lupus report that the disease has a large effect on their emotional and mental well-being.
First Treatment for Children With Systemic Lupus Erythematosus Gets FDA Approval
The Food and Drug Administration (FDA) has approved the intravenous (IV) formulation of Benlysta (belimumab; GlaxoSmithKline) for the treatment of pediatric patients ≥5 years old with active, autoantibody-positive, systemic lupus erythematosus (SLE) who are receiving standard therapy.
The Association Between Skin Diseases and Metabolic Syndrome
Investigators examine the association between various skin conditions and metabolic syndrome.
Second Antimalarial Agent May Be Effective in Cutaneous Lupus Despite Failure of Initial Agent
An observational study evaluated the effect of switching from one antimalarial agent to another agent in cutaneous lupus erythematosus after initial therapy was ineffective or not tolerated.
-
Loading...
-
Loading...
Next post in General Dermatology
